Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;7(1):1.
doi: 10.1186/s13561-016-0141-3. Epub 2017 Jan 13.

Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective

Affiliations

Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective

Klaus Kaier et al. Health Econ Rev. 2017 Dec.

Abstract

ᅟ: We analyze one-year costs and savings of a telemedically supported case management program after kidney transplantation from the perspective of the German Healthcare System. Recipients of living donor kidney transplantation (N = 46) were randomly allocated to either (1) standard aftercare or (2) standard aftercare plus additional telemedically supported case management. A range of cost figures of each patient's medical service utilization were calculated at month 3, 6 and 12 and analyzed using two-part regression models. In comparison to standard aftercare, patients receiving telemedically supported case management are associated with substantial lower costs related to unscheduled hospitalizations (mean difference: €3,417.46 per patient for the entire one-year period, p = 0.003). Taking all cost figures into account, patients receiving standard aftercare are associated, on average, with one-year medical service utilization costs of €10,449.28, while patients receiving telemedically supported case management are associated with €5,504.21 of costs (mean difference: € 4,945.07 per patient, p < 0.001). With estimated expenditures of €3,001.5 for telemedically supported case management of a single patient, we determined a mean difference of €1,943.57, but this result is not statistically significant (p = 0.128). Sensitivity analyses show that the program becomes cost-neutral at around ten participating patients, and was beneficial starting at 15 patients. Routine implementation of telemedically supported case management in German medium and high-volume transplant centers would result in annual cost savings of €791,033 for the German healthcare system. Patients with telemedically supported case management showed a lower utilization of medical services as well as better medical outcomes. Therefore, such programs should be implemented in medium and high-volume transplant centers.

Trial registration: DRKS00007634 ( http://www.drks.de/DRKS00007634 ).

Keywords: Cost-benefit; Cost-of-illness; Telemedicine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Total costs of care. a standard aftercare and b telemedically supported case management
Fig. 2
Fig. 2
Cost savings per patient. a …keeping the fixed costs at a constant level and b …keeping the share of personnel expenses flexible

Similar articles

Cited by

References

    1. Sellares J, De Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. Am J Transplant. 2012;12:388–399. doi: 10.1111/j.1600-6143.2011.03840.x. - DOI - PubMed
    1. Chisholm-Burns M, Pinsky B, Parker G, Johnson P, Arcona S, Buzinec P, Chakravarti P, Good M, Cooper M. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transpl. 2012;26:706–713. doi: 10.1111/j.1399-0012.2011.01589.x. - DOI - PubMed
    1. Denhaerynck K, Steiger J, Bock A, Schäfer-Keller P, Köfer S, Thannberger N, De Geest S. Prevalence and Risk Factors of Non-Adherence with Immunosuppressive Medication in Kidney Transplant Patients. Am J Transplant. 2007;7:108–116. doi: 10.1111/j.1600-6143.2006.01611.x. - DOI - PubMed
    1. Denhaerynck K, Burkhalter F, Schäfer-Keller P, Steiger J, Bock A, De Geest S. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int. 2009;22:441–446. doi: 10.1111/j.1432-2277.2008.00820.x. - DOI - PubMed
    1. Gremigni P, Bacchi F, Turrini C, Cappelli G, Albertazzi A, Bitti PER. Psychological factors associated with medication adherence following renal transplantation. Clin Transpl. 2007;21:710–715. - PubMed

LinkOut - more resources